Behavioral and neurogenomic transcriptome changes in wild-derived zebrafish with fluoxetine treatment
about
Non-mammalian models in behavioral neuroscience: consequences for biological psychiatryZebrafish as an emerging model for studying complex brain disordersSimilar anxiolytic effects of agonists targeting serotonin 5-HT1A or cannabinoid CB receptors on zebrafish behavior in novel environmentsQuantitative cross-species extrapolation between humans and fish: the case of the anti-depressant fluoxetineCurrent concepts in neuroendocrine disruption.Lactobacillus plantarum attenuates anxiety-related behavior and protects against stress-induced dysbiosis in adult zebrafish.Persistent Effects of Developmental Exposure to 17α-Ethinylestradiol on the Zebrafish (Danio rerio) Brain Transcriptome and BehaviorAcute Exposure to Fluoxetine Alters Aggressive Behavior of Zebrafish and Expression of Genes Involved in Serotonergic System RegulationPharmacological and toxicological effects of lithium in zebrafish.Limited sex-biased neural gene expression patterns across strains in Zebrafish (Danio rerio)Characterizing the neurotranscriptomic states in alternative stress coping styles.First quantitative high-throughput screen in zebrafish identifies novel pathways for increasing pancreatic β-cell mass.Neurotranscriptome profiles of multiple zebrafish strains.A de novo transcriptome analysis shows that modulation of the JAK-STAT signaling pathway by salmonid alphavirus subtype 3 favors virus replication in macrophage/dendritic-like TO-cells.Molecular pathways associated with the nutritional programming of plant-based diet acceptance in rainbow trout following an early feeding exposure.Anxiolytic effects of fluoxetine and nicotine exposure on exploratory behavior in zebrafish.Anxiolytic drug discovery: what are the novel approaches and how can we improve them?Zebrafish models of major depressive disorders.Repeatability and reliability of exploratory behavior in proactive and reactive zebrafish, Danio rerio
P2860
Q26781604-962502CB-5378-4D73-945E-D732833DAFB2Q26824393-5EF6EB26-C189-487C-B658-7E2778565E13Q28384182-4912225C-3746-4FEC-9286-1D4AEC0389C8Q28543995-EDB7A5FD-879C-4711-9F0D-73106773908CQ30384415-0911D0F6-C077-4789-AF1E-08636537B474Q30812591-7B8E79FB-7076-4799-9856-33A2C25EC08AQ30846132-E2A03685-2D6E-4D43-9D3B-325294BE4EF8Q33600312-FEB34AB2-690E-4E81-9228-BC820F0167D2Q33777992-7BBFE3BB-634F-4D1F-A61D-B7E55649E551Q34436386-8C8D35F8-1172-4A2B-9D8B-602E302A34FFQ35648793-8911AA7E-FD86-481F-9583-6DA37B7ACBB2Q35947964-875D934D-04A8-4BB2-B00B-82C2BBD14992Q35972413-58E5E507-D8B1-4B34-86A4-40BCDC878C52Q36026936-79BFE94A-E0BB-497A-8DF5-843728B98EAEQ36050749-28C0C252-DCF4-4F6D-8E6F-A234573654A5Q37234026-6AB3EFE2-8189-47AC-BC19-03891141E136Q38160918-79D926BE-F86F-4CDE-9F32-390247895A5DQ38603307-ABEC7950-A765-4CE2-9669-4983ED4A04FEQ58783005-464BD7FC-4009-4021-833E-BEB5E9720335
P2860
Behavioral and neurogenomic transcriptome changes in wild-derived zebrafish with fluoxetine treatment
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Behavioral and neurogenomic tr ...... fish with fluoxetine treatment
@ast
Behavioral and neurogenomic tr ...... fish with fluoxetine treatment
@en
type
label
Behavioral and neurogenomic tr ...... fish with fluoxetine treatment
@ast
Behavioral and neurogenomic tr ...... fish with fluoxetine treatment
@en
prefLabel
Behavioral and neurogenomic tr ...... fish with fluoxetine treatment
@ast
Behavioral and neurogenomic tr ...... fish with fluoxetine treatment
@en
P2860
P356
P1433
P1476
Behavioral and neurogenomic tr ...... fish with fluoxetine treatment
@en
P2093
Sarah E Oxendine
P2860
P2888
P356
10.1186/1471-2164-14-348
P407
P577
2013-05-24T00:00:00Z
P5875
P6179
1028953836